Co-Diagnostics Inc.

NASDAQ: CODX · Real-Time Price · USD
0.30
-0.00 (-0.03%)
At close: Jun 09, 2025, 3:59 PM

Co-Diagnostics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
50.28K 149.32K 641.14K 161.1K 252.75K 3.56M 2.46M 197.81K 601.96K 1.4M 5.09M 5.02M 22.7M 20.4M 30.1M 27.36M 20.02M
Cost of Revenue
21.59K 255.07K 297.4K 550.48K 565.08K 3.28M 255.77K 459.1K 502.24K 515.77K 767.94K 915.43K 3.28M 2.49M 3.31M 2.5M 3.27M
Gross Profit
28.69K -105.74K 343.74K -389.38K -312.33K 274.46K 2.2M -261.29K 99.72K 885.71K 4.33M 4.11M 19.42M 17.91M 26.79M 24.85M 16.75M
Operating Income
-8.55M -11.91M -10.23M -10.18M -10.47M -11.83M -8.94M -11.99M -9.95M 3.84M -6.54M -4.15M 6.54M 10.31M 13.63M 11.79M 10.33M
Interest Income
n/a 123.57K 263.33K 342.19K 362.73K 444.77K 322.88K 191.89K 202.37K 332.8K 298.18K 61.67K 11.39K 9.07K 11.38K 10.53K 14.66K
Pretax Income
-7.52M -11.04M -9.67M -7.58M -9.29M -10.84M -8.1M -11.16M -8.02M -25.04M -3.48M -3.43M 13.1M 10.24M 13.58M 11.93M 9.88M
Net Income
-7.53M -11.03M -9.7M -7.6M -9.31M -14.68M -5.98M -8.92M -5.76M -21.91M -1.36M -2.69M 11.71M 7.5M 11.48M 9.79M 7.9M
Selling & General & Admin
3.43M 6.64M 5.35M 4.17M 4.48M 5.92M 5.05M 5.45M 4.72M 6.58M 5.51M 3.94M 5.57M 5.32M 7.17M 8.32M 4.13M
Research & Development
4.87M 4.81M 4.88M 5.61M 5.68M 6.18M 5.79M 5.98M 5.01M 4.74M 5.04M 3.89M 3.77M 2.18M 5.89M 4.67M 2.22M
Other Expenses
258.86K 357.12K 351.24K 126.19K 96.07K -356.58K 40.57K n/a 316.01K 298.62K 312.49K n/a 247.26K 102.61K 94.04K 71.71K 67K
Operating Expenses
8.56M 11.8M 10.58M 9.79M 10.16M 12.1M 11.14M 11.73M 10.05M 11.62M 10.86M 8.25M 9.59M 7.61M 13.16M 13.06M 6.42M
Interest Expense
n/a n/a n/a n/a n/a 3.39M n/a n/a n/a n/a 298.18K n/a 11.39K 9.07K 11.38K 10.53K 14.66K
Selling & Marketing Expenses
657.03K 818.67K 1.06M 1.04M 1.56M 1.52M 1.9M 1.73M 1.71M 1.33M 1.89M 1.47M 2.65M 2.09M 4.25M 5.85M 1.2M
Cost & Expenses
8.58M 11.06M 10.88M 10.34M 10.73M 15.38M 11.39M 12.19M 10.55M 12.13M 11.63M 9.17M 12.87M 10.09M 16.47M 15.57M 9.69M
Income Tax Expense
12K -8.18K 22.19K 20.59K 22.76K 3.83M -2.11M -2.24M -2.26M -3.14M -2.11M -741.51K 1.39M 2.75M 2.1M 2.15M 1.99M
Shares Outstanding (Basic)
32.05M 33.05M 30.49M 30.12M 29.84M 31.26M 29.36M 29.09M 29.48M 30.87M 31.32M 32.47M 33.94M 28.94M 28.94M 28.79M 28.66M
Shares Outstanding (Diluted)
32.05M 33.05M 30.49M 30.12M 29.84M 31.26M 29.36M 29.09M 29.48M 30.87M 31.32M 32.47M 34.71M 29.95M 29.95M 29.74M 30M
EPS (Basic)
-0.24 -0.36 -0.32 -0.25 -0.31 -0.47 -0.2 -0.31 -0.2 -0.71 -0.04 -0.08 0.35 0.26 0.40 0.34 0.28
EPS (Diluted)
-0.24 -0.36 -0.32 -0.25 -0.31 -0.47 -0.2 -0.31 -0.2 -0.71 -0.04 -0.08 0.34 0.25 0.38 0.33 0.26
EBITDA
-7.24M -11.55M -9.88M -7.34M -9.93M -11.51M -8.64M -11.69M -9.63M -10.43M -6.22M -3.72M 10.07M 10.41M 13.72M 11.86M 10.4M
EBIT
n/a -11.04M -10.23M -7.68M -10.26M -11.83M -8.94M -11.99M -9.95M -10.73M -6.54M -4.15M 13.1M 10.31M 13.58M 11.93M 9.88M
Depreciation & Amortization
280.44K 357.12K 351.24K 338.33K 330.57K 312.88K 296.34K 323.81K 323.46K 311.86K 315.93K 429.34K 256.02K 102.61K 94.04K 71.71K 67K